Last reviewed · How we verify
NCT04775030: CBD-OCC-APP
Methodology for Developing an Occlusal Appliance With CBD Active Carrier
Phase 2, PHASE3 trial testing CBD occlusal appliance in Temporomandibular Disorder in 40 participants. Status unknown.
1 January 2022
Quick facts
| Lead sponsor | Medical University of Silesia |
|---|---|
| Phase | Phase 2, PHASE3 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 1 January 2021 |
| Primary completion | 1 January 2022 |
| Estimated completion | 1 January 2023 |
| Sites | 1 location across Poland |
Drugs / interventions tested
- CBD occlusal appliance — full drug profile →
- Acrylic resin occlusal appliance
Conditions studied
- Temporomandibular Disorder — all drugs for Temporomandibular Disorder →
- Myofascial Pain — all drugs for Myofascial Pain →
- Cannabis — all drugs for Cannabis →
- Electromyography — all drugs for Electromyography →
Sponsor
Medical University of Silesia
Who can join
18 and older, any sex, with Temporomandibular Disorder or Myofascial Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Evaluation of the efficacy of the occlusal appliance with active cannabidiol (CBD) molecules in TMD patients
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04775030
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Temporomandibular Disorder
Currently open trials in the same condition.
- NCT06941636 — Botulinumtoxin A as a Treatment for Myalgia and Myofacial Pain in Patient With Temporomandibulardisorders · Phase 3 · recruiting
- NCT03849534 — Treatment of Temporomandibular Disorders in Children and Adolsecents · NA · recruiting
- NCT06214923 — Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG) · NA · recruiting
- NCT06365151 — An Algorithm for Approaching Temporomandibular Disorders With Osteopathic Manual Therapy in Patients With Fibromyalgia · NA · recruiting
- NCT06357702 — K23- Physical Self Regulation vs Placebo · NA · recruiting
Other Medical University of Silesia trials
Trials by the same sponsor.
- NCT06212674 — Single-stage Pulmonary Vein Isolation Combined With Percutaneous Left Atrial Appendage Occluder Implantation in Patients · Phase 4 · recruiting
- NCT06970002 — Respiratory Stabilization in Chronic Acidosis Before Bronchofiberoscopy & Non-Invasive Ventilation Effectivenes · NA · not yet recruiting
- NCT07137299 — POPQ Associated With Total Laparoscopic Hysterectomy · not yet recruiting
- NCT06970041 — To Assess the Types of Mechanical Ventilation in Enabling Therapeutic Bronchofiberoscopy in Patients With Decompensated · NA · not yet recruiting
- NCT07120529 — Minimally Invasive Surgery Versus Open Radical Hysterectomy in Presumably Early Stage Cervical Cancer: a Retrospective M · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04775030 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical University of Silesia
- Last refreshed: 1 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04775030.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing